Established in 1999, Lepu Medical Technology (Beijing) Co., Ltd. is specialized in high-tech medical device development, production and sales. Lepu has built up a leading group company concentrating in cardiac therapy, with products including interventional cardiology, occlusion devices, prosthetic heart valves, pacemaker, cardiac in vitro diagnosis products, angiographic equipment and anesthetic products. In Oct. 2009, Lepu successfully listed on ChiNext of Shenzhen Stock Exchange market (stock code: 300003).
Lepu Medical Group have 7 wholly-owned and joint stock subsidiary companies, including Shanghai Shape Memory Alloy Co.,Ltd (SHSMA) , Beijing Star Medical Devices Co., Ltd (Star Medical), Beijing Target Medical Technologies, Ltd (Target Medical), Lepu Science & Technology Co., Ltd. (Lepu Technology), Lepu Medical Equipment Co., Ltd (Lepu Equipemnt), and Shaanxi Qinming Medical Co., Ltd.(Qinming Medical).
The headquarter of Lepu Group locates in Changping Technology Park, with over ten thousand square meters clean workshop for production and equipped with more than thousands of advanced production and testing equipments. It has grown up as a development and production medical industry base in China. Until October 2013, Lepu has more than 1600 employees, including hundreds of technical specialists in pharmaceutical, material engineering, electromechanical engineering, precision processing, and medical engineering.
The company upholds “integrity, quality and scientific innovation” as its spirit, dedicating to all medical personnel and patients and providing its best quality of products and services, and strives to build first-class international brand of interventional medical devices.
